STTK Shattuck Labs, Inc.
Healthcare$6.11+0.16%ClosedMarket Cap: $292.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
7.14
P/S
292.21
EV/EBITDA
-4.27
DCF Value
$0.62
FCF Yield
-14.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
-82.0%
Operating Margin
-5266.4%
Net Margin
-4987.4%
ROE
-60.7%
ROA
-48.8%
ROIC
-53.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-15.5M | $-14.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-13.4M | $-12.6M | $— | — |
| FY null | $1.0M | 100.0% | $-51.5M | $-48.8M | $— | — |
| Q3 null | $1.0M | 100.0% | $-10.7M | $-10.1M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-13.0M | $-12.5M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-14.4M | $-13.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-19.6M | $-18.7M | $— | — |
| FY null | $5.7M | 100.0% | $-80.6M | $-75.4M | $— | — |
| Q3 null | $3.0M | 68.2% | $-17.9M | $-16.7M | $— | — |
| Q2 null | $1.6M | 40.2% | $-23.0M | $-21.6M | $— | — |
| Q1 null | $1.1M | 12.6% | $-20.0M | $-18.5M | $— | — |
| Q4 2023 | $714.0K | -37.4% | $-19.0M | $-17.7M | $-0.41 | — |